Structure and function of the ROR2 cysteine-rich domain in vertebrate noncanonical WNT5A signaling

  1. Samuel C Griffiths
  2. Jia Tan
  3. Armin Wagner
  4. Levi L Blazer
  5. Jarret J Adams
  6. Srisathya Srinivasan
  7. Shayan Moghisaei
  8. Sachdev S Sidhu
  9. Christian Siebold  Is a corresponding author
  10. Hsin-Yi Henry Ho  Is a corresponding author
  1. University of Oxford, United Kingdom
  2. University of California, Davis, United States
  3. Diamond Light Source, United Kingdom
  4. University of Waterloo, Canada

Abstract

The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, Brachydactyly B and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Samuel C Griffiths

    Division of Structural Biology, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Jia Tan

    Department of Cell Biology and Human Anatomy, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Armin Wagner

    Science Division, Diamond Light Source, Didcot, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8995-7324
  4. Levi L Blazer

    School of Pharmacy, University of Waterloo, Waterloo, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9594-4642
  5. Jarret J Adams

    School of Pharmacy, University of Waterloo, Waterloo, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Srisathya Srinivasan

    Department of Cell Biology and Human Anatomy, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Shayan Moghisaei

    Department of Cell Biology and Human Anatomy, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Sachdev S Sidhu

    School of Pharmacy, University of Waterloo, Waterloo, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7755-5918
  9. Christian Siebold

    Division of Structural Biology, University of Oxford, Oxford, United Kingdom
    For correspondence
    christian.siebold@strubi.ox.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  10. Hsin-Yi Henry Ho

    Department of Cell Biology and Human Anatomy, University of California, Davis, Davis, United States
    For correspondence
    hyhho@ucdavis.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8780-7864

Funding

National Institutes of Health (1R35GM119574)

  • Hsin-Yi Henry Ho

National Institutes of Health (1R35GM144341)

  • Hsin-Yi Henry Ho

Cancer Research UK (C20724/A26752)

  • Christian Siebold

Wellcome Trust (203141/Z/16/Z)

  • Christian Siebold

Wellcome Trust (099675/Z/12/Z)

  • Samuel C Griffiths

National Institutes of Health (2P30CA093373-19)

  • Hsin-Yi Henry Ho

Cancer Research UK (DRCRPG-May23/100002)

  • Christian Siebold

National Institutes of Health (S10 OD018223)

  • Hsin-Yi Henry Ho

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#21394) of the University of California, Davis. The protocol was approved by the IACUC of the University of California, Davis.

Copyright

© 2024, Griffiths et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,329
    views
  • 216
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Samuel C Griffiths
  2. Jia Tan
  3. Armin Wagner
  4. Levi L Blazer
  5. Jarret J Adams
  6. Srisathya Srinivasan
  7. Shayan Moghisaei
  8. Sachdev S Sidhu
  9. Christian Siebold
  10. Hsin-Yi Henry Ho
(2024)
Structure and function of the ROR2 cysteine-rich domain in vertebrate noncanonical WNT5A signaling
eLife 13:e71980.
https://doi.org/10.7554/eLife.71980

Share this article

https://doi.org/10.7554/eLife.71980

Further reading

    1. Cancer Biology
    2. Developmental Biology
    Sara Jaber, Eliana Eldawra ... Franck Toledo
    Research Article

    Missense ‘hotspot’ mutations localized in six p53 codons account for 20% of TP53 mutations in human cancers. Hotspot p53 mutants have lost the tumor suppressive functions of the wildtype protein, but whether and how they may gain additional functions promoting tumorigenesis remain controversial. Here, we generated Trp53Y217C, a mouse model of the human hotspot mutant TP53Y220C. DNA damage responses were lost in Trp53Y217C/Y217C (Trp53YC/YC) cells, and Trp53YC/YC fibroblasts exhibited increased chromosome instability compared to Trp53-/- cells. Furthermore, Trp53YC/YC male mice died earlier than Trp53-/- males, with more aggressive thymic lymphomas. This correlated with an increased expression of inflammation-related genes in Trp53YC/YC thymic cells compared to Trp53-/- cells. Surprisingly, we recovered only one Trp53YC/YC female for 22 Trp53YC/YC males at weaning, a skewed distribution explained by a high frequency of Trp53YC/YC female embryos with exencephaly and the death of most Trp53YC/YC female neonates. Strikingly, however, when we treated pregnant females with the anti-inflammatory drug supformin (LCC-12), we observed a fivefold increase in the proportion of viable Trp53YC/YC weaned females in their progeny. Together, these data suggest that the p53Y217C mutation not only abrogates wildtype p53 functions but also promotes inflammation, with oncogenic effects in males and teratogenic effects in females.

    1. Developmental Biology
    Mengjie Li, Aiguo Tian, Jin Jiang
    Research Advance

    Stem cell self-renewal often relies on asymmetric fate determination governed by niche signals and/or cell-intrinsic factors but how these regulatory mechanisms cooperate to promote asymmetric fate decision remains poorly understood. In adult Drosophila midgut, asymmetric Notch (N) signaling inhibits intestinal stem cell (ISC) self-renewal by promoting ISC differentiation into enteroblast (EB). We have previously shown that epithelium-derived Bone Morphogenetic Protein (BMP) promotes ISC self-renewal by antagonizing N pathway activity (Tian and Jiang, 2014). Here, we show that loss of BMP signaling results in ectopic N pathway activity even when the N ligand Delta (Dl) is depleted, and that the N inhibitor Numb acts in parallel with BMP signaling to ensure a robust ISC self-renewal program. Although Numb is asymmetrically segregated in about 80% of dividing ISCs, its activity is largely dispensable for ISC fate determination under normal homeostasis. However, Numb becomes crucial for ISC self-renewal when BMP signaling is compromised. Whereas neither Mad RNA interference nor its hypomorphic mutation led to ISC loss, inactivation of Numb in these backgrounds resulted in stem cell loss due to precocious ISC-to-EB differentiation. Furthermore, we find that numb mutations resulted in stem cell loss during midgut regeneration in response to epithelial damage that causes fluctuation in BMP pathway activity, suggesting that the asymmetrical segregation of Numb into the future ISC may provide a fail-save mechanism for ISC self-renewal by offsetting BMP pathway fluctuation, which is important for ISC maintenance in regenerative guts.